Publication:
Survivin, cyclin D1, and p21hras in keratocystic odontogenic tumors before and after decompression

dc.contributor.authorBrajić, I. (57060499200)
dc.contributor.authorŠkodrić, S. (15726145200)
dc.contributor.authorMilenković, S. (57220419015)
dc.contributor.authorTepavčević, Z. (16302346500)
dc.contributor.authorSoldatović, I. (35389846900)
dc.contributor.authorČolić, S. (6508049451)
dc.contributor.authorMilašin, J. (6603015594)
dc.contributor.authorAndrić, M. (20435687400)
dc.date.accessioned2025-06-12T18:54:14Z
dc.date.available2025-06-12T18:54:14Z
dc.date.issued2016
dc.description.abstractObjectives: The aim of this study was to investigate survivin, cyclin D1, and p21hras expression in keratocystic odontogenic tumors before and after decompression, as well as in pericoronal follicles. A potential correlation between the expression levels of these proteins was also investigated. Materials and methods: We analyzed eighteen keratocystic tumors treated by decompression and subsequent enucleation along with seven pericoronal follicles using immunohistochemistry. Results: Keratocystic tumor samples, both before and after decompression, were positive for each of the investigated proteins. In pericoronal follicles, survivin exhibited cytoplasmic staining in contrast to nuclear staining in keratocystic tumors. Cyclin D1 expression was negative in pericoronal follicles, and p21hras expression was similar in both groups. Survivin showed significantly higher expression after decompression, while cyclin D1 and p21hras remained unchanged (P = 0.039, P = 0.255, P = 0.913, respectively). There was no correlation between these proteins neither before nor after decompression. Conclusions: Within the limits of the study, we can conclude that following decompression, keratocystic odontogenic tumors preserve distinct immunohistochemical profiles of cyclin D1 and p21hras expression, despite substantial reduction in size of the lesions. Significant increase of survivin expression after decompression might be attributed to higher level of epithelial proliferation caused by this procedure. © 2016 John Wiley & Sons A/S.
dc.identifier.urihttps://doi.org/10.1111/odi.12414
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-84959352731&doi=10.1111%2fodi.12414&partnerID=40&md5=57f466cfd8a35cab87b4b8261859bdda
dc.identifier.urihttps://remedy.med.bg.ac.rs/handle/123456789/7829
dc.subjectCyclin D1
dc.subjectDecompression
dc.subjectKeratocystic odontogenic tumor
dc.subjectP21hras
dc.subjectSurvivin
dc.titleSurvivin, cyclin D1, and p21hras in keratocystic odontogenic tumors before and after decompression
dspace.entity.typePublication

Files